TYRA
NASDAQ HealthcareTyra Biosciences, Inc. - Common Stock
Biotechnology
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNร P, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is FGFR3, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for intrahepatic cholangiocarcinoma; and TYRA-430 for the treatment of hepatocellular carcinoma. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.
๐ Market Data
| Price | $34.04 |
|---|---|
| Volume | 735,975 |
| Market Cap | 2.02B |
| Beta | 0.960 |
| RSI (14-Day) | 43.7 |
| 200-Day MA | $22.83 |
| 50-Day MA | $35.80 |
| 52-Week High | $40.65 |
| 52-Week Low | $8.75 |
| Forward P/E | -13.27 |
| Price / Book | 7.05 |
๐ฏ Investment Strategy Scores
TYRA scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Moon Shot (67/100) โ this strategy High growth potential (high beta + oversold).
Lowest fit among scored strategies: ๐ Over-Hyped (21/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find TYRA in your text
Paste any article, transcript, or post โ the tool will extract TYRA and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.